Results

Total Results: 839 records

Showing results for "phase".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-therapies-update_disposition-comments.pdf
    December 16, 2014 - Several large multi-institutional Phase III trials for the treatment of prostate cancer involving radiation … very small number of randomized trials when instead it has been evaluated with a very large number of phase … Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration … A phase II study of hypofractionated proton therapy for prostate cancer. … Multi- institutional Phase II study of proton beam therapy for organ-confined prostate cancer focusing
  2. effectivehealthcare.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
    December 01, 2013 - III trials for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … Results The table below lists the 11 topics for which (1) preliminary phase III data on drugs, phase … II data on devices and procedures were available, or programs were in pilot phase; (2) information … Currently, only one registered phase III trial is under way to assess the therapy in patients with … A phase 2b, safety and efficacy study of Boceprevir in patients coinfected with HIV and Hepatitis
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
    March 01, 2024 - RR 1.51; CI 0.03, 76.06 Low All-Cause Mortality Dougan, 202112 29 0/513 15/776 BLAZE-1 PhasePhase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults. … A phase 2a clinical trial of molnupiravir in 35 patients with COVID-19 shows accelerated … Pfizer Announces Additional Phase 2/3 Study Results Confirming Robust Efficacy of Novel COVID-19 Oral … https://www.pfizer.com/news/press- release/press-release-detail/pfizer-announces- additional-phase-23
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults_research-protocol.pdf
    December 20, 2011 - 113493) 31 single blind method/ (15658) 32 clinical trial/ (469154) 33 clinical trial, phase … i.pt. (11784) 34 clinical trial, phase ii.pt. (18612) 35 clinical trial, phase iii.pt. ( … 6631) 36 clinical trial, phase iv.pt. (654) 37 controlled clinical trial.pt. (83741) 38
  5. effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
    January 01, 2013 - Biases introduced by suboptimal study design cannot usually be removed during the statistical analysis phase … define the start of followup, exposure(s), outcome(s), and potential confounders at the study design phase … define the start of followup, exposure(s), outcome(s), and potential confounders at the study design phase … define the start of followup, exposure(s), outcome(s), and potential confounders at the study design phase
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/stem-cell-children_executive.pdf
    February 01, 2012 - comprises a set of narrative reviews and systematic reviews that were defined during the topic refinement phase … Following completion of the topic refinement phase, a Technical Expert Panel (TEP) was formed. … upfront therapy for primary or secondary MDS Allo MH Chronic myelogenous leukemia (CML) Chronic phase … However, during the topic refinement phase of this project, the KIs strongly recommended limiting study
  7. effectivehealthcare.ahrq.gov/sites/default/files/06_devdelays_autism_potential_high_impact_june_2012.pdf
    January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … impact consideration (among the 14 topics being tracked as of May 2012) for which (1) preliminary phase
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/developing-consistent-useful-quality-improvement.pdf
    September 01, 2020 - We then asked two LHS participants to assess the relative value of our criteria in a pilot phase. … In the pilot phase, our two LHS participants felt that some of our 33 criteria were more valuable than … In the exploratory phase, the LHS participants both identified the same four criteria as being most … Assessing the Relative Value of the Criteria In the exploratory phase of the study, we used several … Assessing the Value of the Criteria In the exploratory phase, the two health system representatives
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of … Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine … Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study. … A phase 3 randomized, double-blind, sham- controlled trial of e-TNS for the acute treatment of migraine … Rimegepant for the acute treatment of migraine: subgroup analyses from 3 phase 3 clinical trials by
  10. effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - Value of using 4-phase rhinomanometry in recognition of patients with high nasal resistance and OSA … Other tests could include four-phase rhinomanometry and brain magnetic resonance imaging. … Value of using 4-phase rhinomanometry in recognition of patients with high nasal resistance and OSA … Other diagnostic algorithms and CPRs • Portable monitors • Scoring nasal flow limitation • Four-phase … For example, a run-in phase could allow inclusion of stakeholders, who could be given the opportunity
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0713-140625.pdf
    January 07, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
    November 01, 2020 - We then qualitatively compared performance from the initial modeling phase (i.e., 2017 citations) to … A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with … to osteoarthritis of the knee: a randomized, double-blind, placebo- and C-5 active-controlled phase … the management of severe, chronic low back pain with a neuropathic component: a randomized, d-blind, phase … A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy
  14. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the two topics for which (1) preliminary phase III data for drugs or … of interactive text messaging interventions for this indication; the most developed of these is a phase … The majority of completed studies have been unphased or early-phase clinical trials with limited patient … In July 2014, a group of researchers at the University of Pittsburgh (PA) reported results from a phase
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pwd-care-interventions-protocol.pdf
    February 22, 2019 - Since the PRECIS-2 tool was developed to use during the design phase of a study, this novel use of the … During the development phase, included studies will be assessed individually by all team members and … limit 7 to (adaptive clinical trial or clinical study or clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0648-140819.pdf
    June 24, 2014 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
    September 27, 2022 - Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled … ARISE: A Phase 3 randomized trial of erenumab for episodic migraine. … ti) 21 19 AND ('random sample'/de OR 'randomization'/de OR 'randomized controlled trial'/exp OR ('phase … 3' OR 'phase iii' OR random* OR rct):ti,ab) 22 22 OR 23 23 22 AND [1975-2023]/py I.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
    January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase
  19. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Results The table below lists the five topics for which (1) preliminary phase III data for drugs, at … least phase II or equivalent data for devices and procedures, or some human data for off-label uses … The version of ITCA 650 that will be used in phase III clinical trials is intended to deliver a dose … “Patients on the primary phase 3 dosing 3 regimen lost a mean of 4 kg in the 60 mcg/d ITCA 650 … Available: http://www.intarcia.com/media/press- releases/2014-oct-1-phase-3.html. 10.
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
    September 01, 2016 - 2008, basic summaries of trial results must be submitted for certain applicable trials, including phase … We will limit to phase 3 and 4 trials with completion dates between September 2008 to present.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: